# Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis

> **NCT01044719** · PHASE4 · UNKNOWN · sponsor: **Imperial College London** · enrollment: 240 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Ceftazidime
- **DRUG:** Tobramycin
- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT01044719
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2010-10
- **Final completion:** 2011-04
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2010-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01044719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01044719, "Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01044719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*